Financhill
Back

Phathom Pharmaceuticals Quote, Financials, Valuation and Earnings

Phathom Pharmaceuticals Price Quote

$9.05

Phathom Pharmaceuticals Key Stats

Buy
62
Phathom Pharmaceuticals (PHAT) is a Buy

Day range:
$8.92 - $9.29
52-week range:
$6.07 - $17.02
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
529.7K
Avg. volume:
792.2K
1-year change:
-14.46%
Market cap:
$529.6M
Revenue:
$682K
EPS:
$-3.94

How Much Does Phathom Pharmaceuticals Make?

Data Unavailable

Is Phathom Pharmaceuticals Growing As A Company?

Data Unavailable

Phathom Pharmaceuticals Stock Price Performance

What Is Phathom Pharmaceuticals 52-Week High & Low?

Phathom Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Phathom Pharmaceuticals?

Is Phathom Pharmaceuticals Cash Flow Positive?

  • What Is PHAT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$137.6M
  • What Is Phathom Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $367.6M
  • What Is Phathom Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.6M

Phathom Pharmaceuticals Return On Invested Capital

Data Unavailable

Phathom Pharmaceuticals Earnings Date & Stock Price

Phathom Pharmaceuticals Competitors

Phathom Pharmaceuticals Dividend Yield

Data Unavailable

Phathom Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 20.2%
Revenue: 0% 79.85%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 22.00
Upside from Last Price: 143.09%

Major Shareholders

  • How many PHAT shares are owned by institutional investors?
    54.7M PHAT shares are owned by institutional investors
  • How many PHAT shares are owned by insiders?
    3.4M PHAT shares are owned by insiders